Literature DB >> 15447817

[The protective effect of supplementation of probiotics combined with riboflavin on the intestinal barrier of the rats after scald injury].

Zhong-tang Wang1, Yong-ming Yao, Guang-xia Xiao, Zhi-yong Sheng.   

Abstract

OBJECTIVE: To investigate the effect and its possible mechanism of the supplementation of probiotics combined with riboflavin on the intestinal barriers of the rats after scald injury.
METHODS: Seventy Wistar rats were used in the study and were randomly divided into scald control (SC, n = 30), scald and treatment (ST, n = 30) and normal control (NC, n = 10) groups. The rats in SC and ST groups were subjected to 30% TBSA III degree scald. 1.5 ml of isotonic saline suspension containing 5 x 10(12) CFU/L of Bifidobacteria, 5 x 10(10) CFU/L of Bacillus cereus and 5 mg/L of riboflavin was given to rats by gavage in ST group twice a day. For the rats in SC and NC group equal amount of isotonic saline was fed twice a day. The changes in the incidence of bacterial translocation, the amount of intestinal membranous flora, the synthesis and secretion of SIgA in the ileum, and the repair of injured intestinal mucosa were observed.
RESULTS: The incidence of bacterial translocation in ST group was significantly lower than that in SC group (P = 0.000 - 0.025). The plasma level of endotoxin in ST group was markedly lower than that in SC group on 3 post-scald day (PSD) (P < 0.05). The amount of bifidobacteria in caecal membrane flora increased by about 20 to 40 fold, whereas the amounts of E. coli and fungi significantly decreased (P < 0.01). The membranous injury scoring was 3 to 0 on 5 PSD (P < 0.05), and the SIgA content in intestinal mucus returned to normal value on the 5th PSD (P < 0.01) in the ST group.
CONCLUSION: Supplementation of probiotics together with riboflavin could ameliorate translocation of bacteria and endotoxin in rats with scald injury, implying that the intestinal barrier function was effectively protected.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15447817

Source DB:  PubMed          Journal:  Zhonghua Shao Shang Za Zhi        ISSN: 1009-2587


  3 in total

1.  Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis.

Authors:  J S Bajaj; D M Heuman; P B Hylemon; A J Sanyal; P Puri; R K Sterling; V Luketic; R T Stravitz; M S Siddiqui; M Fuchs; L R Thacker; J B Wade; K Daita; S Sistrun; M B White; N A Noble; C Thorpe; G Kakiyama; W M Pandak; M Sikaroodi; P M Gillevet
Journal:  Aliment Pharmacol Ther       Date:  2014-03-16       Impact factor: 8.171

2.  Qualitative and Quantitative Evaluation of Dietary Intake in Patients with Non-Alcoholic Steatohepatitis.

Authors:  Alessandro Federico; Marcello Dallio; Giuseppe Gerardo Caprio; Antonietta Gerarda Gravina; Desiree Picascia; Mario Masarone; Marcello Persico; Carmela Loguercio
Journal:  Nutrients       Date:  2017-09-28       Impact factor: 5.717

3.  Pretreatment With Bacillus cereus Preserves Against D-Galactosamine-Induced Liver Injury in a Rat Model.

Authors:  Ya-Ting Li; Jian-Zhong Ye; Long-Xian Lv; Hong Xu; Li-Ya Yang; Xian-Wan Jiang; Wen-Rui Wu; Ding Shi; Dai-Qiong Fang; Xiao-Yuan Bian; Kai-Cen Wang; Qiang-Qiang Wang; Jiao-Jiao Xie; Yan-Meng Lu; Lan-Juan Li
Journal:  Front Microbiol       Date:  2019-07-31       Impact factor: 5.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.